T1	Participants 377 414	five-arm treatment optimization study
T2	Participants 494 502	Patients
T3	Participants 881 893	828 patients
T4	Participants 929 963	Seven hundred eighty-four patients
T5	Participants 1005 1029	One hundred ten patients
T6	Participants 1051 1068	3 (21 %) on IM800
T7	Participants 1123 1135	patients â‰¥65
T8	Participants 1274 1288	Older patients
T9	Participants 1365 1390	fast as younger patients,
T10	Participants 1491 1508	younger patients.
T11	Participants 1591 1618	survival for older patients
T12	Participants 1645 1662	younger patients.
T13	Participants 1700 1714	older patients
